Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Seasonality Analysis
Lineage Cell Therapeutics, Inc. Common Stock Annual Seasonality Statistics
Lineage Cell Therapeutics, Inc. Common Stock Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January BEST | 8.04% | Strong | |
| February | -1.82% | Very Weak | |
| March | 1.89% | Weak | |
| April WORST | -3.39% | Very Weak | |
| May | 0.95% | Weak | |
| June | -1.13% | Very Weak | |
| July | 2.25% | Weak | |
| August | 0.29% | Weak | |
| September | 2.13% | Weak | |
| October | 2.29% | Weak | |
| November | 3.83% | Weak | |
| December | 0.08% | Moderate |
Lineage Cell Therapeutics, Inc. Common Stock 2026 vs Historical Pattern
Lineage Cell Therapeutics, Inc. Common Stock Interactive Seasonality Chart
Lineage Cell Therapeutics, Inc. Common Stock Pattern Scanner
Lineage Cell Therapeutics, Inc. Common Stock Seasonal Historical Performance
About Lineage Cell Therapeutics, Inc. Common Stock (LCTX) Seasonality
Lineage Cell Therapeutics, Inc. Common Stock (LCTX) has been analyzed using 27 years of historical data to identify seasonal patterns. Classified under Stocks, Lineage Cell Therapeutics, Inc. Common Stock shows distinct seasonal tendencies based on historical data.
The strongest month for Lineage Cell Therapeutics, Inc. Common Stock is historically January, with an average return of 8.04% and a win rate of 63%. Conversely, April tends to be the weakest month, averaging -3.39% return.
Looking at the full calendar year, Lineage Cell Therapeutics, Inc. Common Stock has an average annual return of 15.39% with an overall monthly win rate of 43.1%. Out of 12 months, 9 typically show positive average returns.
The seasonal pattern for Lineage Cell Therapeutics, Inc. Common Stock has a consistency score of 45.7 (Poor), based on 27 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
Lineage Cell Therapeutics, Inc. Common Stock Seasonality FAQ
What is the best month to buy Lineage Cell Therapeutics, Inc. Common Stock (LCTX)?
Historically, January has been the best month for Lineage Cell Therapeutics, Inc. Common Stock, with an average return of 8.04% and a win rate of 63%. However, past performance does not guarantee future results.
What is the worst month for Lineage Cell Therapeutics, Inc. Common Stock (LCTX)?
Based on historical data, April has been the weakest month for Lineage Cell Therapeutics, Inc. Common Stock, with an average return of -3.39%. This is a historical observation and does not guarantee future results.
How reliable is LCTX seasonality data?
The seasonality analysis for Lineage Cell Therapeutics, Inc. Common Stock is based on 27 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use Lineage Cell Therapeutics, Inc. Common Stock seasonality in my trading?
Use Lineage Cell Therapeutics, Inc. Common Stock (LCTX) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.